Total Payments
$50,584
2024 Payments
$13,582
Companies
15
Transactions
58
Medicare Patients
470
Medicare Billing
$71,610
Payment Breakdown by Category
Consulting$24,361 (48.2%)
Other$19,351 (38.3%)
Food & Beverage$2,981 (5.9%)
Travel$2,952 (5.8%)
Research$940.00 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $24,361 | 10 | 48.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,380 | 9 | 34.4% |
| Food and Beverage | $2,981 | 25 | 5.9% |
| Travel and Lodging | $2,952 | 11 | 5.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,971 | 2 | 3.9% |
| Unspecified | $940.00 | 1 | 1.9% |
Payments by Type
General
$49,644
57 transactions
Research
$940.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $24,869 | 17 | $0 (2024) |
| Eisai Inc. | $9,126 | 5 | $0 (2021) |
| Exelixis Inc. | $4,717 | 6 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $2,393 | 3 | $0 (2017) |
| Servier Pharmaceuticals LLC | $1,971 | 2 | $0 (2021) |
| AstraZeneca UK Limited | $1,925 | 1 | $0 (2021) |
| Halozyme Inc | $1,514 | 12 | $0 (2018) |
| Bard Peripheral Vascular, Inc. | $1,438 | 1 | $0 (2021) |
| PFIZER INC. | $1,405 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $730.95 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,582 | 14 | Boston Scientific Corporation ($13,169) |
| 2023 | $8,700 | 4 | Boston Scientific Corporation ($8,700) |
| 2022 | $600.00 | 1 | Boston Scientific Corporation ($600.00) |
| 2021 | $9,891 | 7 | Boston Scientific Corporation ($2,400) |
| 2020 | $3,560 | 3 | Eisai Inc. ($2,620) |
| 2019 | $429.54 | 2 | PFIZER INC. ($330.00) |
| 2018 | $5,213 | 11 | Exelixis Inc. ($4,717) |
| 2017 | $8,607 | 16 | Eisai Inc. ($4,840) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,650.00 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 12/12/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 12/12/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 12/12/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Travel and Lodging | Cash or cash equivalent | $116.50 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 11/09/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $396.86 | General |
| Category: TheraSphere_PI | ||||||
| 11/08/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $601.80 | General |
| Category: TheraSphere_PI | ||||||
| 11/08/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Travel and Lodging | In-kind items and services | $77.64 | General |
| Category: TheraSphere_PI | ||||||
| 11/07/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Travel and Lodging | In-kind items and services | $433.84 | General |
| Category: TheraSphere_PI | ||||||
| 11/07/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Travel and Lodging | In-kind items and services | $300.55 | General |
| Category: TheraSphere_PI | ||||||
| 11/07/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $191.95 | General |
| Category: TheraSphere_PI | ||||||
| 06/03/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 06/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 05/03/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $143.24 | General |
| Category: BioOncology | ||||||
| 01/05/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 08/25/2023 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: TheraSphere_PI | ||||||
| 07/14/2023 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: TheraSphere_PI | ||||||
| 02/17/2023 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: TheraSphere_PI | ||||||
| 01/20/2023 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
| Category: General - IO Ablation_PI | ||||||
| 11/28/2022 | Boston Scientific Corporation | General - Oncology (Device) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: General - Oncology_URO | ||||||
| 09/19/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $595.95 | General |
| Category: Oncology | ||||||
| 09/10/2021 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/23/2021 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,437.50 | General |
| 06/15/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | In-kind items and services | $422.73 | General |
| Category: ONCOLOGY | ||||||
| 05/20/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | In-kind items and services | $1,547.79 | General |
| Category: ONCOLOGY | ||||||
| 01/20/2021 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $1,562.50 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ONCOLOGY PORTFOLIO CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $940.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 16 | $4,701 | $1,337 |
| 2022 | 5 | 118 | 252 | $60,821 | $20,420 |
| 2021 | 6 | 171 | 305 | $73,315 | $27,578 |
| 2020 | 6 | 166 | 281 | $83,180 | $22,275 |
Total Patients
470
Total Services
854
Medicare Billing
$71,610
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 16 | $4,701 | $1,337 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 91 | $19,483 | $7,217 | 37.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 81 | $23,292 | $7,127 | 30.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 43 | $8,678 | $2,622 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 19 | $5,746 | $2,330 | 40.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 18 | 18 | $3,623 | $1,125 | 31.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 166 | $35,541 | $13,842 | 38.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 32 | 52 | $15,725 | $6,619 | 42.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 29 | $8,184 | $2,573 | 31.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $6,884 | $2,243 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 26 | $3,619 | $1,236 | 34.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 16 | 17 | $3,363 | $1,065 | 31.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 139 | $36,075 | $9,132 | 25.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 37 | 64 | $25,106 | $6,152 | 24.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 22 | 22 | $11,623 | $3,251 | 28.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 28 | $6,317 | $2,512 | 39.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 15 | $1,875 | $672.75 | 35.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 13 | $2,184 | $555.20 | 25.4% |
About Dr. William Harris, MD
Dr. William Harris, MD is a Internal Medicine healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508980194.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Harris, MD has received a total of $50,584 in payments from pharmaceutical and medical device companies, with $13,582 received in 2024. These payments were reported across 58 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($24,361).
As a Medicare-enrolled provider, Harris has provided services to 470 Medicare beneficiaries, totaling 854 services with total Medicare billing of $71,610. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology
- Location Seattle, WA
- Active Since 03/19/2007
- Last Updated 10/23/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508980194
Products in Payments
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) $11,167
- Lenvima (Drug) $9,126
- Cabometyx (Drug) $4,717
- TheraSphere Y90 Glass Microspheres 10 GBq (Device) $4,403
- GENERAL PAIN MANAGEMENT (Device) $2,400
- Nexavar (Drug) $2,393
- TIBSOVO (Drug) $1,971
- IMFINZI (Biological) $730.95
- General - Oncology (Device) $600.00
- OPDIVO (Biological) $220.34
- Tecentriq (Biological) $143.24
- PADCEV (Biological) $135.00
- Xermelo (Drug) $103.05
- FLUZONE HIGH-DOSE (Drug) $16.48
- Imbruvica (Drug) $13.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Seattle
Dr. Gust Bardy, M.d, M.D
Internal Medicine — Payments: $138.3M
Internal Medicine $138.3M
Dr. Peter Shalit, M.d, M.D
Internal Medicine — Payments: $3.5M
Internal Medicine $3.5M
Dr. Stanford Peng, Md, Phd, Facp, MD, PHD, FACP
Internal Medicine — Payments: $2.5M
Internal Medicine $2.5M
Lawrence Fong, Md, MD
Internal Medicine — Payments: $693,314
Internal Medicine $693,314
Dr. Fengting Yan, Md, Phd, MD, PHD
Internal Medicine — Payments: $669,828
Internal Medicine $669,828
Dr. Scott Ramsey, M.d, M.D
Internal Medicine — Payments: $262,526
Internal Medicine $262,526